HomeIPA • NASDAQ
add
Immunoprecise Antibodies Ltd
Previous close
$1.36
Day range
$1.20 - $1.36
Year range
$0.94 - $4.22
Market cap
33.42M USD
Avg Volume
133.45K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Jan 2024info | Y/Y change |
---|---|---|
Revenue | 6.22M | 20.31% |
Operating expense | 6.54M | -13.35% |
Net income | -2.94M | 37.43% |
Net profit margin | -47.26 | 47.99% |
Earnings per share | -0.08 | 41.09% |
EBITDA | -2.41M | 16.74% |
Effective tax rate | 14.96% | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Jan 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 6.20M | -45.21% |
Total assets | 78.69M | -4.55% |
Total liabilities | 28.87M | 35.17% |
Total equity | 49.82M | — |
Shares outstanding | 26.32M | — |
Price to book | 0.72 | — |
Return on assets | -10.82% | — |
Return on capital | -13.27% | — |
Cash Flow
Net change in cash
(CAD) | Jan 2024info | Y/Y change |
---|---|---|
Net income | -2.94M | 37.43% |
Cash from operations | -666.00K | 81.21% |
Cash from investing | 57.00K | 125.22% |
Cash from financing | 613.00K | 317.38% |
Net change in cash | 185.00K | 104.95% |
Free cash flow | 1.66M | 185.81% |
About
Founded
1983
Headquarters
Website
Employees
102